" class="no-js "lang="en-US"> Shahrokh Shariat - Medtech Alert
Thursday, September 11, 2025
Shahrokh Shariat

Shahrokh Shariat

About Shahrokh Shariat

Shahrokh François Shariat (born September 20, 1973) is currently professor and chairman of the department of urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. He is also adjunct professor of urology at Weill Cornell Medical Center, New York, NY; adjunct professor of urology at the University of Texas Southwestern Medical Center, Dallas, TX, USA; adjunct professor of urology at the Faculty of Medicine, Charles University, Prague, CZ; adjunct professor of urology at I.M. Sechenov First Moscow State Medical University, Moscow, RU; honorary professor of urology, University of Jordan, Amman, JO; and doctor honoris causa, Carol Davila University of Medicine and Pharmacy, Bucharest, RO. He has published more than 1400 peer-reviewed research papers, more than 500 non-peer-reviewed papers, and 26 book chapters. He has been voted as the most influential urologist in 2020 and also the most cited PCa researcher in the German speaking area.

Shahrokh Shariat is the recipient of various national and international awards. He has, for example, received the prestigious Matula Award from the European Urological Association and the Gold Cystoscope 2017 from the American Urological Association. He is a member of 25 academic societies and editorial board of 26 scientific journals.

He is an editorial board member of European Urology, BJU International, World Journal of Urology, Current Opinion in Urology (editor in chief), and Immunotherapy among others. He heads a medical charity for refugees and is on the medical advisory board for two other charities. He joined in 2010 the New York Presbyterian Hospital and Weill Cornell Medical Center in New York, NY.

Related Story

Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist

March 25 2022

French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]